Nevertheless, the relationship between T2D and ADP receptor blocker on-treatment platelet reactivity remains inadequately explained [17–19] and further studies would be needed for the final clarification of this issue. This evidence concerns the gene P2RY1 and type 2 diabetes mellitus.